Hypertrichosis cubiti-short stature syndrome

disease
On this page

Also known as hairy elbowshairy elbows syndromehypertrichosis cubitiMacDermot-Patton-Williams syndrome

Summary

Hypertrichosis cubiti-short stature syndrome (MONDO:0007693) is a disease. A subtype of hypertrichosis — broader associated-gene and molecular evidence is on the parent page (see Disease family below).

At a glance

  • Prevalence: <1 / 1 000 000 (Worldwide) [Orphanet-validated]
  • Phenotypes (HPO): 27

Clinical features

Epidemiology

Prevalence records

2 prevalence record(s), Orphanet:

TypeClassValueGeographyValidation
Cases/families28WorldwideValidated
Point prevalence<1 / 1 000 000WorldwideValidated

Signs & symptoms

Clinical features (HPO)

27 HPO clinical features (Orphanet curated; top 27 by frequency):

HPO IDTermFrequency
HP:0002230Generalized hirsutismVery frequent (80-99%)
HP:0002983MicromeliaVery frequent (80-99%)
HP:0003510Severe short statureVery frequent (80-99%)
HP:0008905RhizomeliaVery frequent (80-99%)
HP:0009811Abnormality of the elbowVery frequent (80-99%)
HP:0011121Abnormal skin morphologyVery frequent (80-99%)
HP:0000311Round faceFrequent (30-79%)
HP:0000324Facial asymmetryFrequent (30-79%)
HP:0002300MutismFrequent (30-79%)
HP:0002381AphasiaFrequent (30-79%)
HP:0010529EcholaliaFrequent (30-79%)
HP:0001382Joint hypermobilityOccasional (5-29%)
HP:0000252MicrocephalyOccasional (5-29%)
HP:0000271Abnormality of the faceOccasional (5-29%)
HP:0000348High foreheadOccasional (5-29%)
HP:0000426Prominent nasal bridgeOccasional (5-29%)
HP:0000464Abnormality of the neckOccasional (5-29%)
HP:0000492Abnormal eyelid morphologyOccasional (5-29%)
HP:0000494Downslanted palpebral fissuresOccasional (5-29%)
HP:0000499Abnormal eyelash morphologyOccasional (5-29%)
HP:0000508PtosisOccasional (5-29%)
HP:0000574Thick eyebrowOccasional (5-29%)
HP:0000614Abnormal nasolacrimal system morphologyOccasional (5-29%)
HP:0001249Intellectual disabilityOccasional (5-29%)
HP:0001263Global developmental delayOccasional (5-29%)
HP:0001328Specific learning disabilityOccasional (5-29%)
HP:0002750Delayed skeletal maturationOccasional (5-29%)

Identifiers

Disease identifiers

FieldValue
Canonical namehypertrichosis cubiti-short stature syndrome
Mondo IDMONDO:0007693
MeSHC535618
OMIM139600
Orphanet2220
UMLSC4025295
MedGen870835
GARD0000143
MedDRA10068636
Is cancer (heuristic)no

Also known as: hairy elbows · hairy elbows syndrome · hypertrichosis cubiti · MacDermot-Patton-Williams syndrome

Disease family

This is a subtype of hypertrichosis. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.

Classification path: disease › human disease › disease by body system or component › integumentary system disorder › disorder of pilosebaceous unithypertrichosishypertrichosis cubiti-short stature syndrome

Related subtypes (10): hypertrichosis of eyelid, gingival fibromatosis-hypertrichosis syndrome, cataract-hypertrichosis-intellectual disability syndrome, cervical hypertrichosis-peripheral neuropathy syndrome, Rabson-Mendenhall syndrome, isolated anterior cervical hypertrichosis, acquired hypertrichosis lanuginosa, hypertrichosis lanuginosa congenita, autosomal dominant preaxial polydactyly-upperback hypertrichosis syndrome, hypertrichosis-acromegaloid facial appearance syndrome

Genetics & variants

GWAS landscape

No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.

Variant details and genetic-evidence tiers

No tiered GWAS variants or ClinVar records for this disease.

Genes & proteins

No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).

Function

No pathway enrichment — requires an associated-gene cohort.

Therapeutics

No druggable-target or therapeutic data for this disease’s cohort.

Clinical trials & evidence

Clinical trials

Clinical trials: 0.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.